[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624780":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":11,"centralContacts":25,"locations":32,"responsibleParty":50,"collaborators":11,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":11,"enrollmentInfo":65,"targetDuration":11,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":11,"overallStatus":74,"whyStopped":11,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Assiut University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Group(1)","EXPERIMENTAL",null,[13,14],"Diagnostic Test: Serum level of Human Talin-1","Diagnostic Test: Serum level of Human Cripto-1",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":11},"DIAGNOSTIC_TEST","Serum level of Human Talin-1","To evaluate the clinical utility of Talin-1 measurement in colorectal cancer patients in comparison with healthy controls.",[9],{"type":17,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"Serum level of Human Cripto-1","To evaluate the clinical utility of Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":30,"email":31},"Sherouk Ahmed Sayed, Assistant lecturer","CONTACT","+201123232632","+201009922949","shrookabozaid@gmail.com",[33],{"facility":34,"status":11,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Assuit University Hospital","Asyut","Asyut Governorate","17777","Egypt","EG",{"type":41,"coordinates":42},"Point",[43,44],31.18368,27.18096,{"lat":44,"lon":43},[47],{"name":48,"role":28,"phone":49,"phoneExt":11,"email":11},"Sherouk Ahmed","01123232632",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Shrook S. Ahmed","Assistant lecturer","100624780","serum-talin-1-and-cripto-1-in-colorectal-cancer-100624780",false,"NCT07414082","Serum Talin-1 and Cripto-1 in Colorectal Cancer","Evaluating Serum Talin-1 and Cripto-1 as Diagnostic Biomarkers in Colorectal Cancer","Talin-1\u002FCR-1","Inclusion Criteria:\n\n* Age \\>18 years Old.\n* Patients of both sexes who met the clinical diagnostic criteria of colorectal cancer (change in bowel habit, absolute or recurrent constipation, rectal bleeding, significant weight loss or intestinal obstruction)\n* Patients diagnosed with colorectal cancer by imaging and histopathology\n\nExclusion Criteria:\n\n* Age \\\u003C18 years old.\n* Patients with past history of chemotherapy or surgical excision of tumor\n* Patients with familial adenomatous polyposis\n* Patients with hereditary non-polyposis colorectal cancer\n* Patients with inflammatory bowel disease\n* patients with other types of tumors",true,"ALL","18 Years",{"count":66,"type":67},70,"ESTIMATED","INTERVENTIONAL",[70],"NA","The goals of this study are\n\n* To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.\n* To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA",[73],"Colo-rectal Cancer","NOT_YET_RECRUITING","2026-02-12",{"date":77,"type":78},"2026-02-17","ACTUAL",{"date":80,"type":67},"2026-03-30",{"date":82,"type":67},"2029-12-31",{"name":5,"class":6},1]